An open-label, single-arm, multi-center, phase II clinical trial of single-dose [(131)I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
一项开放标签、单臂、多中心 II 期临床试验,旨在评估单剂量 [(131)I]间碘苄胍治疗难治性嗜铬细胞瘤和副神经节瘤患者的疗效。
期刊:Annals of Nuclear Medicine
影响因子:2.5
doi:10.1007/s12149-021-01699-0
Inaki, Anri; Shiga, Tohru; Tsushima, Yoshito; Jinguji, Megumi; Wakabayashi, Hiroshi; Kayano, Daiki; Akatani, Norihito; Yamase, Takafumi; Kunita, Yuji; Watanabe, Satoru; Hiromasa, Tomo; Mori, Hiroshi; Hirata, Kenji; Watanabe, Shiro; Higuchi, Tetsuya; Tomonaga, Hiroyasu; Kinuya, Seigo